Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 39.99 | N/A |
| PEG Ratio (TTM) | -1.99 | N/A |
| P/S Ratio (TTM) | 5.08 | N/A |
| P/B Ratio (TTM) | 2.58 | N/A |
| P/FCF Ratio (TTM) | 20.94 | N/A |
| Price to 5YR AVG Earnings Ratio | 8.41 | N/A |
| Price to 5YR AVG FCF Ratio | 0.84 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.74% | N/A |
| ROE (TTM) | 6.38% | N/A |
| Net Profit Margin (TTM) | 12.69% | N/A |
| ROIC 5YR AVG | 11.59% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.56% | -27.30% | -15.74% |
| Revenue | 35.79% | -0.04% | 5.68% |
| Net Income | -17.79% | 0.29% | 0.92% |
| Cash Flow | 3.63% | 4.13% | 2.40% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.47 | N/A |
| Quick Ratio (TTM) | 1.25 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | 111.22 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.11 | N/A |
| LTL to 5YR AVG FCF | 1.08 | N/A |
| Shares Outstanding Growth 5YR AVG | 180.00% | N/A |